IIT MoU to Boost Cancer Diagnosis
Kolkata: In a significant step towards enhancing cancer diagnosis and treatment in India, the Indian Institute of Technology (IIT) Kharagpur has signed a Memorandum of Understanding (MoU) with two prestigious institutions: the Variable Energy Cyclotron Centre (VECC) and the Chittaranjan National Cancer Institute (CNCI). This collaboration aims to launch Master of Science (MSc) programs in nuclear medicine and medical physics starting from the academic session of 2026-27.
Objectives of the Collaboration
The primary objective of this partnership is to strengthen cancer diagnosis, treatment, and advanced clinical research in the country. The MSc programs will be offered by IIT Kharagpur’s School of Medical Science and Technology, and they are designed to equip students with the necessary skills and knowledge to contribute effectively to the healthcare sector.
Program Details
Both MSc programs will have a limited intake of 10 students each, ensuring a focused and personalized educational experience. Admission to these programs will be based on the Joint Admission Test for Masters (JAM), which is a competitive examination that assesses the aptitude of candidates for postgraduate studies in various fields of science.
Course Highlights
- Nuclear Medicine: This program will cover the principles and applications of nuclear medicine, including diagnostic imaging and therapeutic techniques.
- Medical Physics: This course will focus on the application of physics principles in medicine, particularly in the context of radiation therapy and imaging technologies.
Future Developments in Healthcare
In addition to the educational programs, IIT Kharagpur also envisions the development of advanced healthcare facilities at the Dr. Syama Prasad Mookerjee Super Speciality Hospital. These facilities will include:
- Day-care chemotherapy services
- Advanced radiology services
- AI-driven cancer technologies
This initiative is expected to significantly enhance the quality of cancer care available to patients in the region.
Signatories of the MoU
The MoU was signed by key representatives from the three institutions involved in this collaboration:
- Suman Chakraborty: Director, IIT Kharagpur
- Jayanta Chakrabarti: Director, Chittaranjan National Cancer Institute
- Sumit Som: Director, Variable Energy Cyclotron Centre
Importance of the Initiative
This collaboration is particularly timely given the increasing prevalence of cancer in India. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality worldwide, and its incidence is on the rise in developing countries including India. By focusing on education and advanced research, this initiative aims to prepare a new generation of healthcare professionals who can tackle the challenges posed by cancer more effectively.
Conclusion
The signing of this MoU marks a pivotal moment in the fight against cancer in India. By combining the strengths of IIT Kharagpur, VECC, and CNCI, this initiative promises to foster innovation in cancer diagnosis and treatment, ultimately benefiting countless patients across the nation.
Note: This article is based on information available as of January 31, 2026, and aims to provide an overview of the recent developments in cancer diagnosis and treatment education in India.
